Investor RelationsGood afternoon fellow investors. I agree with you about the lack of media support and follow up on this great news, BUT the news media is never quick to jump on Phase one study info! It is probably not sensational enough for their blood thirsty appetites!I took your concerns to James, the head investor relations fellow at Protox, and I can tell you, I am happy with my investment future! Please call him and get your own perspective on the value of this company and the future of your investent in it. I am pumped again, hang in there, as the fall is going to provide some more exciting news for us! I have been here since the first offering, and some may think it is an emotional belief, but I am here for the long haul, as I do believe in the future of this wonderful drug.
Don't forget, call James for your own benefit!
Nugie